Construction, expression, and characterization of thymosin alpha 1 tandem repeats in Escherichia coli.
Xue. Xiao-Chang XC; Yan. Zhen Z; Li. Wei-Na WN; Li. Meng M; Qin. Xin X; Zhang. Cun C; Hao. Qiang Q; Wang. Zeng-Lu ZL; Zhao. Ning N; Zhang. Wei W; Zhang. Ying-Qi YQ
Key Findings
- A bacterial system can produce thymosin‑alpha‑1 concatemer (Tα1‑2) efficiently
- The concatemer stimulates T‑cell proliferation more strongly than standard synthetic Tα1
- It significantly up‑regulates IL‑2 receptor expression, indicating enhanced immune activation
Practical Outcomes
- The study shows a way to make large amounts of a potentially more potent thymosin‑alpha‑1 variant, but it requires molecular biology skills and hasn’t been tested in humans. For most biohackers, the immediate takeaway is that the standard synthetic peptide remains the practical option, while the concatemer could become a future, more effective supplement if further safety and dosing data emerge.
Summary
Scientists made a version of the immune‑boosting peptide thymosin‑alpha‑1 that’s linked together in repeats and produced it in bacteria. This repeat form worked better at getting T‑cells to grow and increased a key immune receptor compared to the regular synthetic peptide.
Abstract
Thymosin alpha 1 (T α 1), which is composed of 28 amino acids, has been commercialized worldwide for its immune-modulatory and antitumor effects. T α 1 can stimulate T cell proliferation and differentiation from bone marrow stem cells, augment cell-mediated immune responses, and regulate homeostasis of immune system. In this study, we developed a novel strategy to produce T α 1 concatemer (T α 1③) in Escherichia coli and compared its activity with chemically synthesized T α 1. Results showed that T α 1③ can more effectively stimulate T cell proliferation and significantly upregulate IL-2 receptor expression. We concluded that the expression system for T α 1 concatemer was constructed successfully, which could serve as an efficient tool for the production of large quantities of the active protein.
Study Information
pubmed
2013
2013-02-28T00:00:00.000Z
10.1155/2013/720285
7
16